期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

首发急性心肌梗死患者可溶性血栓调节蛋白水平对近期预后的影响 被引量：1

First-episode Patients with Acute Myocardial Infarction Soluble Thrombomodulin Levels on the Evaluation of Short-term Prognosis
下载PDF
导出
摘要 目的探讨首发急性心肌梗死(AMI)患者血浆可溶性血栓调节蛋白(soluble thrombomodulin,sTM)水平对近期预后的影响。方法将74例首发AMI患者分为有心血管事件组21例,无心血管事件组53例。应用酶联免疫吸附法(ELISA)检测2组sTM的血浆浓度。结果有心血管事件组sTM水平(7.27±1.76)ng/L;无心血管事件组sTM水平(4.48±0.97)ng/L,2组比较差异有统计学意义(P<0.05)。结论AMI患者可溶性血栓调节蛋白水平对近期预后有良好的评价作用。 Objective： To investigate the first patients with acute myocardial infarction Soluble thrombomodulin （sTM） in the evaluation of short-term prognosis. Methods 74 cases of first-epi- sode AMI will be different 2 Groups,there cardiovascular events be 2i cases,no cardiovascular events be 53 cases, enzyme-linked immunosorbent assay （ELISA） for measurement of plasma con- centrations of sTM. Results There cardiovascular events sTM level （7.27!1.76）ng/L;no cardiovascular events sTM levels （4.48± 0.97） ng/L, respectively, the difference was significant （P〈0.05）. Conclusion The first patients with acute myocardial infarction Soluble thrombomodulin levels will be on the short-term prognosis good evaluation role.
作者 方文锦 王云开 欧阳长生
机构地区 景德镇市第二人民医院心内科 南昌大学第一附属医院心内科
出处 《实用临床医学（江西）》 CAS 2008年第9期23-25,共3页 Practical Clinical Medicine
关键词 可溶性血栓调节蛋白 急性心肌梗死 预后 soluble thrombomodulin acute myocardial infarction prognosis
分类号 R542.22 [医药卫生—心血管疾病]
  • 相关文献

参考文献8

  • 1Blann A D, Tabemer D A. A Reliable Marker of Endothelial Cell Dysfunction : Does it Exist? [J]. Br J Haematol, 1995,2 : 244-248.
  • 2Smomaa V,Wu K K. Soluble Thrombomodulin as Predictor of Incident Coronary Heart Disease[J]. Lancet, 1999,354: 1646- 1647.
  • 3Blann A D, Mccolum C N. Yon Wilebrand Factor and Soluble Tmombomodulin as Predictors of Adverse Events Among Subjects with Peripheral or Coronary Athemsclemsis[J]. Blood Coagul Fibrinolysis, 1999,10 : 375-380.
  • 4Kokame K, Zheng X,Sadler J E, et al. Activation of Thmmbinaetivable Fibrinolysis Inhibitor Requires Epidermal Growth Factor Liake Domain 3 of Thrombomodulin and is Inhibited Competitively by Protein C[J]. J Bio Chem. 1998,273 (20) 12135-12139.
  • 5张雪姣,唐安丽,廖新学,吴敬国,马虹.可溶性血栓调节蛋白与冠心病患者短期预后的关系[J].中山大学学报（医学科学版）,2006,27(B03):135-137. 被引量：2
  • 6Morrow D A,Rifai N,Antman E M ,et al. C-reactive Protein is a Potent Predictor of Mortality Independendy of and in Combination with Tropinin T in Acute Coronary Syndrome:a 11MI 11A Substudy. Thrombolysis in Myocardial Infarction[J]. J Am Coll Cardiol, 1998,31(7) : 1460-1465.
  • 7Salomaa V, Matei C, Aieksic N, et al. Soluble Thrombomodulin as a Predictor of Incident Coronary Heart Disease and Symptomless Carotid Artery Atherosclemsis in the Athemsclemsis Risk in Communities (ARIC) Study: a Casecohort Study [ J]. Lancet, 1999,353(9166) : 1729-1734.
  • 8Wu K K, Kenneth K. Soluble Thrombomodulin and Coronary Heart Disease[J]. Curr Opin Lipidol, 2003,14(4) : 373-375.

二级参考文献10

  • 1SALOMAA V,WU K K.Soluble thrombomodulin as predictor of incident coronary heart disease[J].Lancet,1999,354(9190):1646-1647.
  • 2CORTELLARO M,BOSCHETTI C,COFRANCESCO E,et al.The PLAT study:hemostatic factors in relation to atherothrombotic ischaemic events in vascular disease patients[J].Arterioscl Thromb,1992,12(9):1063-1069.
  • 3VIOLI F,CRQUI M,LONGONI A,et al.Relationship between risk factors and cardiovascular disease in patients with peripheral vascular disease.Results from the A.D.E.P.study[J].Atherosclerosis,1996,120(1-2):25-32.
  • 4BLANN A D,SEIGNEUR M,STEINER M,et al.Circulating endothelial cell marker in peripheral vascular disaese:relationship to the location and extent of atherosclerotic disease[J].Eur J Clin Investi,1997,27(11):916-921.
  • 5SHAH P K.New insights into the pathogenesis and prevention of acute coronary syndrome[J].Am J Cardiol,1997,79(12B):17-23.
  • 6BLANN A D,AMIRAL J,McCOLLUM C N.Prognostic value of increased soluble thrombomodulin and increased soluble Eselection in ischaemic heart disease[J].Eur J Haematol,1997,59(2):115-117.
  • 7MORROW D A,RIFAI N,ANTMAN E M,et al.C-reactive protein is a potent predictor of mortality independently of and in combination with tropinin T in acute coronary syndrome:a TIMI 11A substudy.Thrombolysis in myocardial infarction[J].J Am Coll Cardiol,1998,31 (7):1460-1465.
  • 8KOKAME K,ZHENG X,SADLER J E,et al.Activation of thrombinactivable fibrinolysis inhibitor requires epidermal growth factor liake domain 3 of thrombomodulin and is inhibited competitively by protein C[J].J Bio Chem,1998,273(20):12135-12139.
  • 9SALOMAA V,MATEI C,ALEKSIC N,et al.Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study:a casecohort study[J].Lancet,1999,353(9166):1729-1734.
  • 10WU,KENNETH K.Soluble thrombomodulin and coronary heart disease[J].Curr Opin Lipidol,2003,14(4):373-375.

共引文献1

同被引文献8

引证文献1

二级引证文献2

实用临床医学（江西）
2008年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部